Centiva Capital, LP Tilray Brands, Inc. Transaction History

Centiva Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.6 - $2.48 $56,390 - $87,405	35,244 New	35,244 $87,000
Q3 2023 Nov 14, 2023	BUY	$1.55 - $3.31 $42,260 - $90,247	27,265 New	27,265 $65,000
Q1 2022 May 16, 2022	SELL	$4.88 - $8.56 $623,917 - $1.09 Million	-127,852 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.03 - $13.03 $898,799 - $1.67 Million	127,852 New	127,852 $899,000
Q2 2020 Aug 14, 2020	SELL	$5.54 - $10.81 $60,147 - $117,364	-10,857 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.47 - $21.36 $26,816 - $231,905	10,857 New	10,857 $75,000

403

99.9M

8.59M

8.9M

Ticker TLRY
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 611,401,984
Market Cap $825M
Description
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.